Transvaginal endometrial sonography in postmenopausal women taking tamoxifen

Obstetrics and Gynecology

Volumn 93, Issue 3, 1999, Pages 363-366

  Tesoro, Michael R ^a   Borgida, Adam F ^a   MacLaurin, Nancy A ^a   Asuncion, Celedonio M ^a  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; POLYP; POSTMENOPAUSE; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY; UTERINE TUBE DISEASE;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; RETROSPECTIVE STUDIES; TAMOXIFEN; ULTRASONOGRAPHY; UTERINE DISEASES; VAGINA;

EID: 0033104320     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00418-9     Document Type: Article

References (13)

1. Early Breast Cancer Trialists' Collaborative Group . Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women . Lancet. 339:1992;1-15.
2. Fisher B., Costantino J., Redmond L., Poisson R., Bowman D., Couture J., et al. A randomized, clinical trial evaluating tamoxifen in the treatment of women with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 320:1989;479-484.
3. Baum M., Brinkley D.M., Dosset J.A. Controlled trial of tamoxifen as a single adjuvant agent in management of early breast cancer. Br J Cancer. 57:1988;609-611.
4. Lahti E., Blanco G., Kauppila A., Apaja-Sarkkinen M., Taskinen P.J., Laatikainen T. Endometrial changes in postmenopausal breast cancer women receiving tamoxifen. Obstet Gynecol. 81:1993;660-664.
5. Fisher B., Constantino J.P., Redmond C.K., Fisher E.R., Wickerham D.L., Cronin W.M. Endometrial cancer in tamoxifen treated breast cancer women Findings from the national surgical adjuvant breast and bowel project (NSABP) B-14 . J Natl Cancer Inst. 86:1994;527-537.
6. Malfetano J.H. Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients. Gynecol Oncol. 39:1990;82-84.
7. Cheng W.F., Lin H.H., Torng P.L., Huang S.C. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Gynecol Oncol. 66:1997;233-237.
8. Fornander T., Rutqvist L.E., Cedarmark B., Mattsson A., Skoog L., Theve T. Adjuvant tamoxifen in early breast cancer Occurrence of new primary cancers . Lancet. 1:1989;117-120.
9. Kedar R.P., Bourne T.H., Powles T.J., Collins W.P., Asley S.E., Cosgrove D.O., et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial. Lancet. 343:1994;1318-1321.
10. Bese T., Kosebay D., Demirkiran F., Arvas M., Bese N., Mandel N. Ultrasonographic appearance of endometrium in postmenopausal breast cancer women receiving tamoxifen. Eur J Obstet Gynecol Reprod Biol. 67:1996;157-162.
11. Achiron R., Lipitz S., Sivan E., Goldenberg M., Mashiach S. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium. J Ultrasound Med. 14:1995;685-688.
12. Goldstein S. Unusual ultrasonographic appearance of the uterus in women receiving tamoxifen. Am J Obstet Gynecol. 170:1994;447-451.
13. Cohen I., Rosen D., Tepper R., Cordoba M., Shapira V., Altaras M.M., et al. Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal women treated with tamoxifen. J Ultrasound Med. 12:1993;275-280.